Skip to content

Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence

The Effect of Remote Monitoring and Support for Patients Suffering From Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence to Treatment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02665611
Enrollment
300
Registered
2016-01-28
Start date
2016-02-29
Completion date
2018-01-31
Last updated
2016-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Schizoaffective Disorder, Schizophrenia

Brief summary

Moma call center will provide unique service -Remote monitoring and support for mental health patients .The aim of this reserch is reducing hospitalization and improve adherence, by reaching out and there for monitoring very closely .

Detailed description

Moma call center is a result of collaboration between Maccabi Health Services and The Gertner Institute of Epidemiology and Health Policy Research. The call center provides remote continuous monitoring and support for patients with chronic illnesses, and has been found useful for improvement in treatment adherence and other clinical measures in patients with diabetes and CHF. The current project focuses on patients diagnosed with schizophrenia, schizoaffective disorder and bipolar disorder. Patients that suffer from these disorders are prone to low adherence and are at risk for discontinuation of treatment and frequent relapses. The advantages of the Moma call-center include high availability, reaching out, collaboration between treatment centers and agents, and continuous remote monitoring. We hypothesize that these factors will enable improvement of support provided to these patients, early detection of their needs, connection with community care agents, monitoring of treatment adherence, and remote interventions targeted towards prevention of relapse.

Interventions

BEHAVIORALintervention for improvement of adherence

intervention for improvement of adherence

BEHAVIORALtreatment as usual

The control group will be treated according to the usual stadard of care.

Sponsors

Sheba Medical Center
CollaboratorOTHER_GOV
Assuta Hospital Systems
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Men & women, 1. age 18-60 , 2. Maccabi Health service patients with diagnosis of: schizophrenia, Schizo - effective or Bipolar Dis. 3. Must have 30 days or more of hospitalization (during 3 years). Treated with psychiatric medication. 4. Living independently or with a help of a caregiver. 5. Is able to provide written informed consent.

Exclusion criteria

1. Violent, or suicidal. 2. Drug\\ Alcohol, addiction, 3. End stage Disease (Cancer, ESRF act.) 4. Non - in depended and without Care giver/legal guardian

Design outcomes

Primary

MeasureTime frame
number of days of hospitalizationthrough study competion ,an average of 1 year.

Contacts

Primary ContactMeytal L Kahlon, MA
kahlon_me@mac.org.il+972-52-8568283
Backup ContactYifat L Danon, MA
yifatad@gmail.com+972-50-8210625

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026